- Home
- TCX vs ACIU Comparison
TCX vs ACIU Comparison
Compare TCX & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCX
- ACIU
- Stock Information
- Founded
- TCX 1992
- ACIU 2003
- Country
- TCX Canada
- ACIU Switzerland
- Employees
- TCX N/A
- ACIU N/A
- Industry
- TCX EDP Services
- ACIU Biotechnology: Pharmaceutical Preparations
- Sector
- TCX Technology
- ACIU Health Care
- Exchange
- TCX Nasdaq
- ACIU Nasdaq
- Market Cap
- TCX 215.1M
- ACIU 173.7M
- IPO Year
- TCX 1996
- ACIU 2016
- Fundamental
- Price
- TCX $17.00
- ACIU $1.68
- Analyst Decision
- TCX
- ACIU Strong Buy
- Analyst Count
- TCX 0
- ACIU 2
- Target Price
- TCX N/A
- ACIU $10.00
- AVG Volume (30 Days)
- TCX 21.7K
- ACIU 134.5K
- Earning Date
- TCX 05-08-2025
- ACIU 04-30-2025
- Dividend Yield
- TCX N/A
- ACIU N/A
- EPS Growth
- TCX N/A
- ACIU N/A
- EPS
- TCX N/A
- ACIU N/A
- Revenue
- TCX $369,427,000.00
- ACIU $32,014,254.00
- Revenue This Year
- TCX N/A
- ACIU N/A
- Revenue Next Year
- TCX N/A
- ACIU $676.94
- P/E Ratio
- TCX N/A
- ACIU N/A
- Revenue Growth
- TCX 6.66
- ACIU 91.20
- 52 Week Low
- TCX $13.27
- ACIU $1.43
- 52 Week High
- TCX $26.48
- ACIU $4.98
- Technical
- Relative Strength Index (RSI)
- TCX 54.72
- ACIU 46.75
- Support Level
- TCX $16.25
- ACIU $1.55
- Resistance Level
- TCX $17.08
- ACIU $1.79
- Average True Range (ATR)
- TCX 0.64
- ACIU 0.10
- MACD
- TCX 0.15
- ACIU 0.03
- Stochastic Oscillator
- TCX 58.29
- ACIU 66.67
About TCX Tucows Inc.
Tucows Inc is a corporate parent, allocating capital and providing efficient shared services to its three businesses. The Company offers Mobile Service Enabler (MSE) solutions, as well as professional services to other retail mobile providers. The Company is also a distributor of Internet services, including domain name registration, digital certificates, and email. It provides these services through an Internet-based distribution network of Internet Service Providers, web hosting companies, and other providers of Internet services to end-users. It operates in three segments: Ting, Wavelo, and Tucows Domains. It generates the majority of its revenue from Tucows Domains.
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.